News

Almac and the departments of Biochemical Engineering and Chemistry at UCL are set to complete the R&D work with high level input from professors John Ward and Helen

The safety and tolerability profile of single ascending doses of TTI-1612 will be assessed in the study. Stem Cell Therapeutics chief scientific officer Dr. Bob Uger said, "We

The new anti-bacterial agents will be based on a highly validated target family involved in bacterial cell wall biosynthesis. Evotec CEO Dr Werner Lanthaler said, "The lack of

The product is presently in the development stage for the treatment of chemotherapy-induced nausea and vomiting (CINV). As per the terms of the deal, Vifor Pharma will not

The power of cognitive computing capabilities, such as IBM’s Watson, will be exploited under the project. The project will leverage big data and analytics to deliver personalised care

The transaction includes Iberogast and Laif brands indicated for the treatment of functional gastrointestinal disorders and for the treatment of mild to moderate depression respectively. The privately held

ORMD-0801 is an orally ingestible insulin capsule indicated for the early stages of type 2 diabetes, when it can still slow the rate of degeneration of the disease

The new lab allows the company to better support the business needs of its clients by increasing efficiency during discovery and development, and providing consistency in the stages

The company has received the final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fenofibrate, which is the generic